Related Experiment Videos
Cromolyn sodium in the treatment of asthma: its effectiveness and use
Insights
Cromolyn sodium significantly reduced asthma symptoms like wheezing and cough in children compared to placebo. This new drug showed a marked preference, proving useful as an additional treatment for pediatric asthma control.
Area of Science:
- Pediatric Pulmonology
- Clinical Pharmacology
Background:
- Asthma is a common chronic respiratory disease in children.
- Corticosteroids are a primary treatment, but alternative therapies are sought.
- Cromolyn sodium is an emerging pharmaceutical agent for asthma management.
Purpose of the Study:
- To evaluate the efficacy and patient preference of cromolyn sodium versus placebo in pediatric asthma.
- To assess cromolyn sodium's effectiveness in children not primarily using corticosteroids.
Main Methods:
- A double-blind, crossover study design was employed.
- Thirty-six asthmatic children participated.
- Participants received both cromolyn sodium and placebo for comparison.
Main Results:
- Significant reductions in wheezing, breathlessness, and cough were observed with cromolyn sodium compared to placebo.
- A strong patient preference for cromolyn sodium over placebo was reported.
- The drug was found effective even in children not on corticosteroids.
Conclusions:
- Cromolyn sodium demonstrates significant efficacy in alleviating asthma symptoms in children.
- The drug is well-tolerated and preferred by patients over placebo.
- Cromolyn sodium is a valuable adjunct therapy for pediatric asthma management.
Abstract:
Thirty-six asthmatic children received placebo and cromolyn sodium, a new drug, in a double-blind crossover study; the majority were not using corticosteroids. Significant decreases in wheezing, breathlessness at rest, and cough occurred when the active drug was compared to placebo. Marked preference for cromolyn over placebo was expressed at the end of the study. Our results agree with previous reports on the effectiveness of cromolyn sodium. We found this drug to be especially useful as an adjunct to other treatment in the control of asthmatic children.